반응식
Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([O:14][CH2:15][CH2:16][CH2:17][N:18]3[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]3)=[C:9]([O:12][CH3:13])[CH:10]=2)[N:5]=[CH:4][N:3]=1.C(=O)([O-])[O-].[K+].[K+].[CH3:30][C:31]1[C:39]2[C:34](=[CH:35][CH:36]=[C:37]([OH:40])[CH:38]=2)[NH:33][CH:32]=1>CC(N(C)C)=O>[CH3:13][O:12][C:9]1[CH:10]=[C:11]2[C:6](=[CH:7][C:8]=1[O:14][CH2:15][CH2:16][CH2:17][N:18]1[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]1)[N:5]=[CH:4][N:3]=[C:2]2[O:40][C:37]1[CH:38]=[C:39]2[C:34](=[CH:35][CH:36]=1)[NH:33][CH:32]=[C:31]2[CH3:30]참가 물질
5
반응 조건
- 온도
- 100 °C
실험 절차
A mixture of 4-chloro-6-methoxy-7-(3-piperidinopropoxy)quinazoline (168 mg, 0.5 mmol), (prepared as described for the starting material in Example 67), potassium carbonate (207 mg, 1.5 mmol), 3-methyl-5-hydroxyindole (88 mg, 0.6 mmol), (Can. J. Chem. 1964, 42, 514), and DMA (2.0 ml) was purged with nitrogen for 5 minutes at 25° C. This mixture was then stirred at 100° C. for 3 hours then allowed to cool to ambient temperature, was filtered and the filtrate evaporated under vacuum. The residue was purified by silica column chromatography eluting with dichloromethane/methanolic ammonia (7M) (90/10) to give 6-methoxy-4-(3-methylindol-5-yloxy)-7-(3-piperidinopropoxy)quinazoline (155 mg, 69%).
후처리
- custom(prepared
- customwas purged with nitrogen for 5 minutes at 25° C
- temperatureto cool to ambient temperature
- filtrationwas filtered
- customthe filtrate evaporated under vacuum
- customThe residue was purified by silica column chromatography
- washeluting with dichloromethane/methanolic ammonia (7M) (90/10)
출처 및 근거
- ORD 기록
- ord-6810790b5ad8493290ee02a8938ad3c6
- 출처 데이터셋
- uspto-grants-2006_07
- 특허 번호
- US07074800B1
연결된 노트
불러오는 중…